These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 18286727)

  • 21. The NIDA Methamphetamine Clinical Trials Group: a strategy to increase clinical trials research capacity.
    Elkashef A; Rawson RA; Smith E; Pearce V; Flammino F; Campbell J; Donovick R; Gorodetzky C; Haning W; Mawhinney J; McCann M; Weis D; Williams L; Ling W; Vocci F
    Addiction; 2007 Apr; 102 Suppl 1():107-13. PubMed ID: 17493059
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An open-label pilot study of risperidone in the treatment of methamphetamine dependence.
    Meredith CW; Jaffe C; Yanasak E; Cherrier M; Saxon AJ
    J Psychoactive Drugs; 2007 Jun; 39(2):167-72. PubMed ID: 17703711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuropsychological function and delay discounting in methamphetamine-dependent individuals.
    Hoffman WF; Moore M; Templin R; McFarland B; Hitzemann RJ; Mitchell SH
    Psychopharmacology (Berl); 2006 Oct; 188(2):162-70. PubMed ID: 16915378
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Legal measures in illicit drug detection: Management of urine tests in psychiatric treatment of methamphetamine dependence patients].
    Matsumoto T
    Chudoku Kenkyu; 2011 Sep; 24(3):193-7. PubMed ID: 21950017
    [No Abstract]   [Full Text] [Related]  

  • 25. Bupropion for the treatment of methamphetamine dependence.
    Elkashef AM; Rawson RA; Anderson AL; Li SH; Holmes T; Smith EV; Chiang N; Kahn R; Vocci F; Ling W; Pearce VJ; McCann M; Campbell J; Gorodetzky C; Haning W; Carlton B; Mawhinney J; Weis D
    Neuropsychopharmacology; 2008 Apr; 33(5):1162-70. PubMed ID: 17581531
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An emerging problem: methamphetamine abuse among treatment seeking youth.
    Gonzales R; Ang A; McCann MJ; Rawson RA
    Subst Abus; 2008; 29(2):71-80. PubMed ID: 19042326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of methamphetamine use disorders: an update.
    Rawson RA; Gonzales R; Brethen P
    J Subst Abuse Treat; 2002 Sep; 23(2):145-50. PubMed ID: 12220612
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Parallel Effects of Methamphetamine on Anxiety and CCL3 in Humans and a Genetic Mouse Model of High Methamphetamine Intake.
    Huckans M; Wilhelm CJ; Phillips TJ; Huang ET; Hudson R; Loftis JM
    Neuropsychobiology; 2017; 75(4):169-177. PubMed ID: 29402784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An exploration of self-perceived non-problematic use as a barrier to professional support for methamphetamine users.
    Quinn B; Stoové M; Papanastasiou C; Dietze P
    Int J Drug Policy; 2013 Nov; 24(6):619-23. PubMed ID: 23867050
    [No Abstract]   [Full Text] [Related]  

  • 30. [Prevalence and Therapy of Crystal Methamphetamine Dependence].
    Soyka M; Koller G; Proebstl L; Kamp F; Franke A; Schmidt P; Baumgärtner G; Schacht-Jablonowsky M; Sievert A; Straif M; Hamdorf W
    Fortschr Neurol Psychiatr; 2017 Feb; 85(2):92-99. PubMed ID: 28235211
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A double-blind, placebo-controlled trial of modafinil (200 mg/day) for methamphetamine dependence.
    Shearer J; Darke S; Rodgers C; Slade T; van Beek I; Lewis J; Brady D; McKetin R; Mattick RP; Wodak A
    Addiction; 2009 Feb; 104(2):224-33. PubMed ID: 19149817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Psychiatric comorbidity of methamphetamine dependence in a forensic sample.
    Kalechstein AD; Newton TF; Longshore D; Anglin MD; van Gorp WG; Gawin FH
    J Neuropsychiatry Clin Neurosci; 2000; 12(4):480-4. PubMed ID: 11083165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preintervention Profiles of Information, Motivational, and Behavioral Self-Efficacy for Methamphetamine Use and HIV Medication Adherence Among Gay and Bisexual Men.
    Starks TJ; Millar BM; Lassiter JM; Parsons JT
    AIDS Patient Care STDS; 2017 Feb; 31(2):78-86. PubMed ID: 28092450
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of psychotic symptoms in subjects with methamphetamine versus cocaine dependence.
    Alexander PD; Gicas KM; Willi TS; Kim CN; Boyeva V; Procyshyn RM; Smith GN; Thornton AE; Panenka WJ; Jones AA; Vila-Rodriguez F; Lang DJ; William MacEwan G; Honer WG; Barr AM
    Psychopharmacology (Berl); 2017 May; 234(9-10):1535-1547. PubMed ID: 28190084
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low concentrations of methamphetamine detectable in urine in the presence of high concentrations of amphetamine.
    Jemionek JF; Addison J; Past MR
    J Anal Toxicol; 2009 Apr; 33(3):170-3. PubMed ID: 19371467
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparing the effect of buprenorphine and methadone in the reduction of methamphetamine craving: a randomized clinical trial.
    Ahmadi J; Razeghian Jahromi L
    Trials; 2017 Jun; 18(1):259. PubMed ID: 28587620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Brief intervention for students with methamphetamine use disorders: a randomized controlled trial.
    Srisurapanont M; Sombatmai S; Boripuntakul T
    Am J Addict; 2007; 16(2):111-6. PubMed ID: 17453612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contingency management for the treatment of methamphetamine use disorders.
    Roll JM; Petry NM; Stitzer ML; Brecht ML; Peirce JM; McCann MJ; Blaine J; MacDonald M; DiMaria J; Lucero L; Kellogg S
    Am J Psychiatry; 2006 Nov; 163(11):1993-9. PubMed ID: 17074952
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The cognitive impairments and psychological wellbeing of methamphetamine dependent patients compared with health controls.
    Zhong N; Jiang H; Du J; Zhao Y; Sun H; Xu D; Li C; Zhuang W; Li X; Hashimoto K; Zhao M
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Aug; 69():31-7. PubMed ID: 27085943
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two-year outcomes of treatment for methamphetamine use.
    Brecht ML; Greenwell L; von Mayrhauser C; Anglin MD
    J Psychoactive Drugs; 2006 Nov; Suppl 3():415-26. PubMed ID: 17357533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.